- Home
- CVAC vs OPRA Comparison
CVAC vs OPRA Comparison
Compare CVAC & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- OPRA
- Stock Information
- Founded
- CVAC 2000
- OPRA 1996
- Country
- CVAC Germany
- OPRA Norway
- Employees
- CVAC N/A
- OPRA N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- OPRA Computer Software: Prepackaged Software
- Sector
- CVAC Health Care
- OPRA Technology
- Exchange
- CVAC Nasdaq
- OPRA Nasdaq
- Market Cap
- CVAC 1.2B
- OPRA 1.4B
- IPO Year
- CVAC 2020
- OPRA 2018
- Fundamental
- Price
- CVAC $5.41
- OPRA $17.01
- Analyst Decision
- CVAC Hold
- OPRA Strong Buy
- Analyst Count
- CVAC 3
- OPRA 5
- Target Price
- CVAC $6.83
- OPRA $24.90
- AVG Volume (30 Days)
- CVAC 404.4K
- OPRA 804.0K
- Earning Date
- CVAC 11-11-2025
- OPRA 10-28-2025
- Dividend Yield
- CVAC N/A
- OPRA 4.65%
- EPS Growth
- CVAC N/A
- OPRA N/A
- EPS
- CVAC 1.01
- OPRA 0.90
- Revenue
- CVAC $599,540,810.00
- OPRA $554,721,000.00
- Revenue This Year
- CVAC N/A
- OPRA $26.28
- Revenue Next Year
- CVAC $23.83
- OPRA $14.72
- P/E Ratio
- CVAC $5.40
- OPRA $19.95
- Revenue Growth
- CVAC 675.15
- OPRA 29.84
- 52 Week Low
- CVAC $2.37
- OPRA $12.83
- 52 Week High
- CVAC $5.72
- OPRA $22.50
- Technical
- Relative Strength Index (RSI)
- CVAC 53.41
- OPRA 41.34
- Support Level
- CVAC $5.33
- OPRA $18.39
- Resistance Level
- CVAC $5.45
- OPRA $21.06
- Average True Range (ATR)
- CVAC 0.03
- OPRA 0.98
- MACD
- CVAC 0.01
- OPRA -0.29
- Stochastic Oscillator
- CVAC 66.10
- OPRA 7.02
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About OPRA Opera Limited
Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.